← Back to Browse
🏥
Healthcare Stocks
477 stocks • 85 A-rated • 87 B-rated
Showing 477 stocks
Exelixis, Inc.
EXEL
99
$69.57
$17.3B cap
Grade A
IDEXX Laboratories, Inc.
IDXX
99
$676.04
$52.8B cap
Grade A
Puma Biotechnology, Inc.
PBYI
98
$8.25
$369M cap
Grade A
Medpace Holdings, Inc.
MEDP
98
$653.11
$17.8B cap
Grade A
BeOne Medicines AG
ONC
98
$406.96
$41.4B cap
Grade A
AnaptysBio, Inc.
ANAB
98
$46.45
$1.4B cap
Grade A
Corcept Therapeutics Incorporated
CORT
98
$72.77
$7.7B cap
Grade A
Electromed, Inc.
ELMD
98
$27.17
$222M cap
Grade A
Indivior Pharmaceuticals Inc
INDV
98
$36.28
$4.5B cap
Grade A
InfuSystem Holdings, Inc.
INFU
98
$13.69
$270M cap
Grade A
IRadimed Corporation
IRMD
98
$86.31
$1.1B cap
Grade A
Ironwood Pharmaceuticals, Inc.
IRWD
98
$4.39
$666M cap
Grade A
Mettler-Toledo International Inc.
MTD
98
$1722.15
$33.6B cap
Grade A
Theravance Biopharma Inc
TBPH
98
$17.03
$738M cap
Grade A
Tactile Systems Technology, Inc.
TCMD
98
$26.03
$591M cap
Grade A
Nutex Health, Inc.
NUTX
97
$180.56
$1.3B cap
Grade A
biote Corp.
BTMD
97
$1.06
$46M cap
Grade A
Chemed Corporation
CHE
97
$528.05
$6.9B cap
Grade A
Catalyst Pharmaceuticals, Inc.
CPRX
97
$31.49
$2.4B cap
Grade A
DexCom, Inc.
DXCM
97
$79.41
$31.5B cap
Grade A
Guardian Pharmacy Services, Inc.
GRDN
97
$42.39
$2.5B cap
Grade A
Inspire Medical Systems, Inc.
INSP
97
$63.98
$1.9B cap
Grade A
Lantheus Holdings, Inc.
LNTH
96
$100.61
$6.6B cap
Grade A
Aurinia Pharmaceuticals Inc.
AUPH
96
$16.46
$2.2B cap
Grade A
Gilead Sciences, Inc.
GILD
96
$166.89
$207.8B cap
Grade A
Halozyme Therapeutics, Inc.
HALO
96
$103.63
$14.0B cap
Grade A
Talkspace, Inc.
TALK
96
$5.25
$611M cap
Grade A
Viemed Healthcare, Inc.
VMD
96
$9.13
$343M cap
Grade A
Eli Lilly and Company
LLY
95
$1354.00
$1.3T cap
Grade A
Insulet Corp.
PODD
95
$146.51
$10.8B cap
Grade A
Incyte Corporation
INCY
95
$119.65
$24.1B cap
Grade A
Novo Nordisk A/S
NVO
95
$40.31
$177.7B cap
Grade A
Universal Health Services, Inc.
UHS
95
$195.50
$10.3B cap
Grade A
Zoetis Inc.
ZTS
95
$79.40
$33.9B cap
Grade A
Neurocrine Biosciences, Inc.
NBIX
94
$164.63
$16.2B cap
Grade A
Progyny, Inc.
PGNY
94
$34.84
$2.6B cap
Grade A
Alkermes plc
ALKS
94
$45.90
$7.5B cap
Grade A
Arrowhead Pharmaceuticals, Inc.
ARWR
94
$58.16
$8.1B cap
Grade A
Penumbra, Inc.
PEN
94
$319.21
$12.7B cap
Grade A
SANUWAVE Health Inc.
SNWV
94
$5.73
$19M cap
Grade A
Rallybio Corporation
RLYB
93
$15.75
$77M cap
Grade A
Masimo Corporation
MASI
93
$179.95
$7.6B cap
Grade A
Niagen Bioscience Inc
NAGE
93
$2.07
$167M cap
Grade A
Acadia Pharmaceuticals Inc.
ACAD
93
$21.23
$3.7B cap
Grade A
Oscar Health, Inc.
OSCR
93
$30.65
$8.6B cap
Grade A
Rigel Pharmaceuticals, Inc.
RIGL
92
$39.65
$854M cap
Grade A
Black Diamond Therapeutics, Inc.
BDTX
92
$1.74
$95M cap
Grade A
Bioventus Inc.
BVS
92
$10.61
$731M cap
Grade A
InMode Ltd.
INMD
92
$13.33
$771M cap
Grade A
United Therapeutics Corporation
UTHR
92
$562.02
$24.3B cap
Grade A
MiMedx Group, Inc.
MDXG
91
$3.31
$479M cap
Grade A
Ardent Health Inc.
ARDT
91
$17.30
$2.2B cap
Grade A
Vertex Pharmaceuticals Incorporated
VRTX
91
$547.09
$137.5B cap
Grade A
AbbVie Inc.
ABBV
90
$291.31
$509.4B cap
Grade A
Bristol-Myers Squibb Company
BMY
90
$62.14
$129.0B cap
Grade A
Collegium Pharmaceutical, Inc.
COLL
90
$24.21
$819M cap
Grade A
Enhabit, Inc.
EHAB
90
$13.80
$406M cap
Grade A
The Joint Corp.
JYNT
90
$6.85
$104M cap
Grade A
National HealthCare Corporation
NHC
90
$208.85
$2.9B cap
Grade A
Johnson & Johnson
JNJ
89
$276.22
$655.6B cap
Grade A
Kiniksa Pharmaceuticals International, plc
KNSA
89
$93.86
$6.9B cap
Grade A
Quipt Home Medical Corp.
QIPT
89
$3.65
$154M cap
Grade A
Align Technology, Inc.
ALGN
89
$166.00
$11.3B cap
Grade A
Apellis Pharmaceuticals, Inc.
APLS
89
$41.03
$2.9B cap
Grade A
AstraZeneca PLC
AZN
89
$186.43
$289.8B cap
Grade A
Elevance Health Inc.
ELV
89
$425.62
$93.7B cap
Grade A
Healthcare Services Group, Inc.
HCSG
89
$24.28
$1.7B cap
Grade A
Redcare Pharmacy N.V.
SHPPF
89
$64.80
$1.6B cap
Grade A
Waters Corporation
WAT
89
$457.60
$44.5B cap
Grade A
Delcath Systems, Inc.
DCTH
88
$14.93
$503M cap
Grade A
Illumina, Inc.
ILMN
88
$213.13
$31.4B cap
Grade A
Bio-Techne Corporation
TECH
88
$72.78
$11.4B cap
Grade A
Travere Therapeutics, Inc.
TVTX
88
$49.60
$4.7B cap
Grade A
ANI Pharmaceuticals, Inc.
ANIP
87
$67.41
$1.6B cap
Grade A
Edwards Lifesciences Corporation
EW
87
$102.14
$58.1B cap
Grade A
Amicus Therapeutics, Inc.
FOLD
87
$14.49
$4.4B cap
Grade A
Krystal Biotech, Inc.
KRYS
87
$300.88
$8.9B cap
Grade A
Encompass Health Corporation
EHC
86
$137.54
$13.9B cap
Grade A
Exact Sciences Corporation
EXAS
86
$104.91
$19.3B cap
Grade A
GSK plc
GSK
86
$50.33
$101.0B cap
Grade A
Novartis AG
NVS
86
$162.55
$305.8B cap
Grade A
TransMedics Group, Inc.
TMDX
86
$88.24
$2.4B cap
Grade A
Pharming Group N.V.
PHAR
85
$12.29
$871M cap
Grade A
HCA Healthcare, Inc.
HCA
85
$494.99
$106.0B cap
Grade A
Stryker Corporation
SYK
85
$325.78
$127.6B cap
Grade A
Community Health Systems, Inc.
CYH
84
$2.21
$322M cap
Grade B
Globus Medical, Inc.
GMED
84
$71.05
$10.9B cap
Grade B
Harrow Health, Inc.
HROW
84
$26.89
$976M cap
Grade B
Jazz Pharmaceuticals plc
JAZZ
84
$234.76
$14.6B cap
Grade B
Merck & Co., Inc.
MRK
84
$146.71
$362.5B cap
Grade B
Addus HomeCare Corporation
ADUS
83
$124.31
$2.4B cap
Grade B
CorMedix Inc.
CRMD
83
$5.32
$408M cap
Grade B
UnitedHealth Group Incorporated
UNH
83
$394.15
$355.2B cap
Grade B
Agilent Technologies, Inc.
A
82
$174.76
$48.4B cap
Grade B
Amgen Inc.
AMGN
82
$460.42
$248.8B cap
Grade B
BioMarin Pharmaceutical Inc.
BMRN
82
$56.03
$10.9B cap
Grade B
CareDx, Inc
CDNA
81
$78.56
$4.0B cap
Grade B
Innoviva, Inc.
INVA
81
$19.10
$1.4B cap
Grade B
Pediatrix Medical Group, Inc.
MD
80
$31.29
$2.5B cap
Grade B
ADMA Biologics, Inc.
ADMA
80
$12.73
$3.0B cap
Grade B
Haemonetics Corporation
HAE
80
$119.93
$5.6B cap
Grade B
Organon & Co.
OGN
80
$13.87
$3.6B cap
Grade B
Alnylam Pharmaceuticals, Inc.
ALNY
79
$155.94
$21.0B cap
Grade B
Boston Scientific Corporation
BSX
79
$42.75
$64.7B cap
Grade B
Quest Diagnostics Incorporated
DGX
79
$255.63
$28.1B cap
Grade B
Avanos Medical, Inc.
AVNS
79
$24.99
$536M cap
Grade B
Tenet Healthcare Corporation
THC
79
$283.33
$22.8B cap
Grade B
Novavax, Inc.
NVAX
78
$10.78
$1.6B cap
Grade B
Regeneron Pharmaceuticals, Inc.
REGN
78
$904.35
$93.4B cap
Grade B
Sanofi
SNY
78
$47.04
$112.4B cap
Grade B
AMN Healthcare Services, Inc.
AMN
77
$36.19
$1.8B cap
Grade B
Harmony Biosciences Holdings, Inc.
HRMY
77
$33.11
$1.9B cap
Grade B
TG Therapeutics, Inc.
TGTX
77
$59.83
$8.9B cap
Grade B
Henry Schein, Inc.
HSIC
76
$86.05
$9.5B cap
Grade B
Innovage Holding Corp.
INNV
76
$8.97
$1.2B cap
Grade B
Qiagen N.V.
QGEN
76
$50.33
$10.5B cap
Grade B
Vericel Corporation
VCEL
76
$54.62
$2.7B cap
Grade B
Amphastar Pharmaceuticals, Inc.
AMPH
75
$28.49
$1.2B cap
Grade B
Centene Corp.
CNC
75
$69.70
$36.7B cap
Grade B
FONAR Corporation
FONR
75
$19.09
$118M cap
Grade B
Q32 Bio Inc.
QTTB
74
$9.25
$263M cap
Grade B
Royalty Pharma plc
RPRX
74
$67.30
$30.1B cap
Grade B
DaVita Inc.
DVA
74
$191.35
$12.3B cap
Grade B
iRhythm Technologies, Inc.
IRTC
74
$90.22
$4.3B cap
Grade B
Xeris Biopharma Holdings, Inc.
XERS
74
$15.20
$2.4B cap
Grade B
Labcorp Holdings Inc.
LH
73
$366.57
$29.5B cap
Grade B
Supernus, Inc.
SUPN
73
$26.16
$1.6B cap
Grade B
Orthofix Medical Inc.
OFIX
72
$7.87
$361M cap
Grade B
Amneal Pharmaceuticals, Inc.
AMRX
72
$20.14
$6.8B cap
Grade B
CONMED Corporation
CNMD
72
$51.50
$1.6B cap
Grade B
UFP Technologies, Inc.
UFPT
72
$303.47
$2.3B cap
Grade B
Esperion Therapeutics, Inc.
ESPR
71
$3.18
$525M cap
Grade B
Koninklijke Philips N.V.
PHG
71
$30.35
$25.2B cap
Grade B
Dr. Reddy's Laboratories Limited
RDY
71
$14.91
$12.1B cap
Grade B
McKesson Corporation
MCK
70
$1060.84
$125.0B cap
Grade B
Phibro Animal Health Corporation
PAHC
70
$32.96
$1.4B cap
Grade B
Integer Holdings Corporation
ITGR
70
$126.56
$4.3B cap
Grade B
Organogenesis Holdings Inc.
ORGO
68
$0.81
$108M cap
Grade B
Emergent BioSolutions Inc.
EBS
68
$6.06
$300M cap
Grade B
Galapagos N.V.
GLPG
68
$27.98
$1.9B cap
Grade B
Soleno Therapeutics, Inc.
SLNO
68
$53.01
$3.6B cap
Grade B
XOMA Royalty Corp.
XOMA
68
$40.17
$468M cap
Grade B
XOMA Corporation
XOMAP
68
$24.98
$307M cap
Grade B
Auna S.A.
AUNA
67
$4.68
$340M cap
Grade B
The Ensign Group, Inc.
ENSG
67
$181.08
$10.6B cap
Grade B
IQVIA Holdings Inc.
IQV
67
$271.83
$43.7B cap
Grade B
SI-BONE, Inc.
SIBN
67
$24.24
$1.1B cap
Grade B
Thermo Fisher Scientific Inc.
TMO
67
$694.76
$250.8B cap
Grade B
Abbott Laboratories
ABT
66
$109.93
$196.6B cap
Grade B
Concentra Group Holdings Parent, Inc.
CON
66
$42.22
$5.4B cap
Grade B
Lakefront Biotherapeutics N.V.
LKFT
66
$33.45
$2.2B cap
Grade B
Cigna Corporation
CI
65
$293.59
$79.7B cap
Grade B
Castle Biosciences, Inc.
CSTL
65
$32.52
$1.0B cap
Grade B
Fresenius Medical Care AG & Co. KGaA
FMS
65
$23.40
$12.6B cap
Grade B
Zimmer Biomet Holdings, Inc.
ZBH
65
$105.59
$20.4B cap
Grade B
Varex Imaging Corporation
VREX
64
$18.44
$783M cap
Grade B
Arcutis Biotherapeutics, Inc.
ARQT
63
$25.55
$3.4B cap
Grade B
Biogen Inc.
BIIB
63
$248.35
$36.1B cap
Grade B
Cardinal Health, Inc.
CAH
63
$271.72
$62.0B cap
Grade B
Champions Oncology, Inc.
CSBR
63
$4.79
$66M cap
Grade B
GE HealthCare Technologies Inc.
GEHC
63
$82.38
$37.9B cap
Grade B
Kamada Ltd.
KMDA
63
$7.23
$396M cap
Grade B
Takeda Pharmaceutical Company Limited
TAK
63
$21.02
$51.0B cap
Grade B
LivaNova PLC
LIVN
62
$89.99
$5.0B cap
Grade B
Novocure Ltd
NVCR
62
$13.28
$1.6B cap
Grade B
Pacira BioSciences, Inc.
PCRX
62
$36.43
$1.5B cap
Grade B
Teva Pharmaceutical Industries Limited
TEVA
62
$42.61
$48.7B cap
Grade B
LifeStance Health Group, Inc.
LFST
61
$13.77
$5.1B cap
Grade B
Option Care Health, Inc.
OPCH
61
$31.65
$4.7B cap
Grade B
Amarin Corporation plc
AMRN
60
$11.61
$239M cap
Grade B
Cerus Corporation
CERS
60
$2.02
$430M cap
Grade B
Zevra Therapeutics, Inc.
ZVRA
60
$11.59
$625M cap
Grade B
Natera, Inc.
NTRA
59
$310.67
$52.4B cap
Grade C
Akebia Therapeutics, Inc.
AKBA
59
$0.40
$118M cap
Grade C
Hims & Hers Health, Inc.
HIMS
59
$26.00
$5.4B cap
Grade C
Sotera Health Company
SHC
59
$16.01
$4.5B cap
Grade C
Grifols, S.A.
GRFS
58
$8.43
$6.8B cap
Grade C
Alignment Healthcare, Inc.
ALHC
58
$7.34
$1.6B cap
Grade C
Danaher Corporation
DHR
58
$230.25
$159.1B cap
Grade C
Prestige Consumer Healthcare Inc.
PBH
58
$42.98
$2.1B cap
Grade C
PACS Group, Inc.
PACS
57
$49.60
$8.0B cap
Grade C
Alphatec Holdings, Inc.
ATEC
56
$7.44
$1.2B cap
Grade C
Bio-Rad Laboratories, Inc.
BIO
56
$381.57
$9.9B cap
Grade C
Charles River Laboratories International, Inc.
CRL
56
$337.52
$15.0B cap
Grade C
Artivion, Inc.
AORT
55
$20.21
$1.2B cap
Grade C
U.S. Physical Therapy, Inc.
USPH
55
$99.49
$1.5B cap
Grade C
Cencora, Inc.
COR
54
$333.56
$64.8B cap
Grade C
CVS Health Corp.
CVS
54
$83.85
$104.0B cap
Grade C
Inogen, Inc.
INGN
54
$6.03
$180M cap
Grade C
ImmuCell Corporation
ICCC
53
$9.80
$90M cap
Grade C
10x Genomics, Inc.
TXG
53
$59.28
$7.0B cap
Grade C
Ardelyx, Inc.
ARDX
52
$2.88
$745M cap
Grade C
Ascendis Pharma A/S
ASND
51
$256.82
$16.7B cap
Grade C
Immunocore Holdings plc
IMCR
51
$30.99
$1.5B cap
Grade C
Elanco Animal Health Incorporated
ELAN
50
$25.74
$11.8B cap
Grade C
ICON Public Limited Company
ICLR
50
$204.74
$15.1B cap
Grade C
Molina Healthcare, Inc.
MOH
50
$208.99
$11.3B cap
Grade C
GeneDx Holdings Corp.
WGS
50
$62.37
$1.9B cap
Grade C
Bausch Health Companies Inc.
BHC
47
$8.18
$3.0B cap
Grade C
Viatris Inc.
VTRS
47
$19.91
$21.8B cap
Grade C
Tarsus Pharmaceuticals, Inc.
TARS
46
$68.60
$3.3B cap
Grade C
Eton Pharmaceuticals, Inc.
ETON
45
$56.46
$1.3B cap
Grade C
Aytu BioPharma, Inc.
AYTU
44
$1.83
$18M cap
Grade C
Establishment Labs Holdings Inc.
ESTA
40
$67.02
$1.9B cap
Grade C
Glaukos Corporation
GKOS
40
$224.41
$13.0B cap
Grade C
Integra LifeSciences Holdings Corporation
IART
40
$13.42
$1.1B cap
Grade C
Septerna Inc
SEPN
40
$48.85
$2.2B cap
Grade C
Axsome Therapeutics, Inc.
AXSM
39
$132.37
$6.8B cap
Grade D
NeuroPace, Inc.
NPCE
38
$12.50
$436M cap
Grade D
Tandem Diabetes Care, Inc.
TNDM
38
$16.91
$1.3B cap
Grade D
Trulieve Cannabis Corp.
TRLV
38
$11.56
$1.9B cap
Grade D
PTC Therapeutics, Inc.
PTCT
37
$65.44
$5.5B cap
Grade D
Brookdale Senior Living Inc.
BKD
37
$9.01
$2.6B cap
Grade D
Fortrea Holdings Inc.
FTRE
37
$21.96
$1.9B cap
Grade D
High Tide Inc.
HITI
36
$2.63
$234M cap
Grade D
Neogen Corporation
NEOG
34
$11.76
$2.5B cap
Grade D
Bruker Corporation
BRKR
34
$61.31
$8.8B cap
Grade D
OrthoPediatrics Corp.
KIDS
34
$31.76
$841M cap
Grade D
Great Elm Group, Inc.
GEG
33
$2.18
$68M cap
Grade D
Cronos Group Inc.
CRON
32
$3.61
$1.4B cap
Grade D
RxSight, Inc.
RXST
31
$4.54
$189M cap
Grade D
AdaptHealth Corp.
AHCO
31
$7.33
$1.0B cap
Grade D
Cumberland Pharmaceuticals Inc.
CPIX
31
$5.22
$90M cap
Grade D
NeoGenomics, Inc.
NEO
30
$16.84
$2.1B cap
Grade D
The Pennant Group, Inc.
PNTG
30
$36.36
$1.4B cap
Grade D
Clover Health Investments, Corp.
CLOV
30
$4.82
$2.4B cap
Grade D
Cryo-Cell International, Inc.
CCEL
30
$4.89
$40M cap
Grade D
Ligand Pharmaceuticals Incorporated
LGND
28
$306.20
$6.0B cap
Grade D
Protagonist Therapeutics, Inc.
PTGX
28
$132.04
$8.8B cap
Grade D
Treace Medical Concepts, Inc.
TMCI
28
$4.03
$272M cap
Grade D
RadNet, Inc.
RDNT
27
$76.00
$6.1B cap
Grade D
Evolus, Inc.
EOLS
27
$6.80
$449M cap
Grade D
Rockwell Medical, Inc.
RMTI
26
$7.73
$31M cap
Grade D
Veracyte, Inc.
VCYT
26
$52.52
$1.9B cap
Grade D
Madrigal Pharmaceuticals, Inc.
MDGL
25
$399.63
$9.2B cap
Grade D
Acadia Healthcare Company, Inc.
ACHC
25
$37.00
$3.2B cap
Grade D
Perrigo Company plc
PRGO
25
$15.85
$2.2B cap
Grade D
Lumexa Imaging Holdings, Inc. Common Stock
LMRI
25
$13.43
$1.3B cap
Grade D
Adaptive Biotechnologies Corporation
ADPT
23
$27.98
$4.3B cap
Grade D
BioNTech SE
BNTX
22
$87.51
$21.3B cap
Grade D
Monte Rosa Therapeutics, Inc.
GLUE
22
$10.57
$874M cap
Grade D
Aurora Cannabis Inc.
ACB
21
$5.24
$329M cap
Grade D
Astrana Health, Inc.
ASTH
21
$34.50
$1.9B cap
Grade D
Cytek Biosciences, Inc.
CTKB
21
$5.83
$702M cap
Grade D
Gyre Therapeutics, Inc.
GYRE
21
$4.76
$425M cap
Grade D
IDEAYA Biosciences, Inc.
IDYA
21
$31.24
$3.0B cap
Grade D
Organigram Global Inc.
OGI
21
$0.88
$160M cap
Grade D
Sonoma Pharmaceuticals, Inc.
SNOA
21
$1.11
$2M cap
Grade D
Sensus Healthcare, Inc.
SRTS
21
$2.86
$48M cap
Grade D
P3 Health Partners Inc.
PIII
20
$4.00
$13M cap
Grade D
Sonida Senior Living, Inc.
SNDA
20
$32.78
$1.6B cap
Grade D
Ionis Pharmaceuticals, Inc.
IONS
19
$39.42
$6.4B cap
Grade F
Burning Rock Biotech Limited
BNR
19
$13.42
$11M cap
Grade F
InterCure Ltd.
INCR
19
$3.47
$281M cap
Grade F
Tilray Brands, Inc.
TLRY
19
$2.92
$314M cap
Grade F
BillionToOne, Inc.
BLLN
18
$113.94
$5.3B cap
Grade F
Enovis Corporation
ENOV
18
$27.16
$1.7B cap
Grade F
Fulgent Genetics, Inc.
FLGT
18
$23.74
$513M cap
Grade F
Protalix BioTherapeutics, Inc.
PLX
18
$2.54
$202M cap
Grade F
Legend Biotech Corporation
LEGN
17
$23.40
$4.2B cap
Grade F
MannKind Corporation
MNKD
17
$3.90
$1.2B cap
Grade F
Phathom Pharmaceuticals, Inc.
PHAT
17
$5.25
$413M cap
Grade F
PROCEPT BioRobotics Corporation
PRCT
17
$20.62
$1.2B cap
Grade F
Day One Biopharmaceuticals, Inc.
DAWN
17
$21.53
$729M cap
Grade F
Enanta Pharmaceuticals, Inc.
ENTA
17
$11.00
$294M cap
Grade F
Janux Therapeutics, Inc.
JANX
17
$17.63
$982M cap
Grade F
Zymeworks Inc.
ZYME
16
$29.63
$2.1B cap
Grade F
Spero Therapeutics, Inc.
SPRO
16
$1.03
$168M cap
Grade F
Sarepta Therapeutics, Inc.
SRPT
16
$17.82
$1.9B cap
Grade F
OmniAb, Inc.
OABI
15
$5.03
$705M cap
Grade F
Biodesix, Inc.
BDSX
15
$19.84
$162M cap
Grade F
Journey Medical Corporation
DERM
15
$4.47
$121M cap
Grade F
Fennec Pharmaceuticals Inc.
FENC
15
$9.81
$329M cap
Grade F
Surgery Partners, Inc.
SGRY
15
$23.20
$3.0B cap
Grade F
Strata Critical Medical, Inc.
SRTA
15
$5.56
$465M cap
Grade F
Zai Lab Limited
ZLAB
15
$25.48
$2.5B cap
Grade F
OPKO Health, Inc.
OPK
14
$1.73
$1.3B cap
Grade F
AxoGen, Inc.
AXGN
14
$50.02
$2.9B cap
Grade F
Enlivex Therapeutics Ltd.
ENLV
14
$1.27
$21M cap
Grade F
Neuronetics, Inc.
STIM
14
$2.15
$185M cap
Grade F
Concord Medical Services Holdings Limited
CCM
14
$3.71
$1M cap
Grade F
Lifecore Biomedical, Inc.
LFCR
13
$6.36
$243M cap
Grade F
Butterfly Network, Inc.
BFLY
13
$6.37
$1.6B cap
Grade F
Canopy Growth Corporation
CGC
13
$0.65
$286M cap
Grade F
Evaxion Biotech A/S
EVAX
13
$3.00
$17M cap
Grade F
Guardant Health, Inc.
GH
13
$150.87
$20.6B cap
Grade F
Agilon Health, Inc.
AGL
12
$113.39
$1.9B cap
Grade F
CeriBell, Inc.
CBLL
12
$26.59
$1.0B cap
Grade F
Codexis, Inc.
CDXS
12
$1.08
$112M cap
Grade F
Sight Sciences, Inc.
SGHT
12
$10.08
$538M cap
Grade F
Grace Therapeutics, Inc.
GRCE
11
$1.85
$29M cap
Grade F
Biofrontera Inc.
BFRI
11
$0.83
$11M cap
Grade F
Maravai LifeSciences Holdings, Inc.
MRVI
11
$7.52
$2.0B cap
Grade F
Roivant Sciences Ltd.
ROIV
11
$38.88
$26.5B cap
Grade F
Alvotech
ALVO
11
$4.86
$1.6B cap
Grade F
Geron Corporation
GERN
11
$0.99
$610M cap
Grade F
Alpha Teknova, Inc.
TKNO
11
$7.81
$486M cap
Grade F
Twist Bioscience Corporation
TWST
11
$120.79
$7.9B cap
Grade F
Vireo Growth Inc.
VREOF
11
$6.53
$256M cap
Grade F
SIGA Technologies, Inc.
SIGA
11
$3.10
$341M cap
Grade F
Valneva SE
VALN
11
$5.51
$529M cap
Grade F
Xencor, Inc.
XNCR
11
$35.75
$2.5B cap
Grade F
CG Oncology Inc.
CGON
10
$75.99
$5.7B cap
Grade F
Fulcrum Therapeutics, Inc.
FULC
10
$3.70
$281M cap
Grade F
Century Therapeutics, Inc.
IPSC
10
$1.68
$273M cap
Grade F
SCYNEXIS, Inc.
SCYX
10
$3.50
$37M cap
Grade F
Seer, Inc.
SEER
10
$1.63
$90M cap
Grade F
Exagen Inc.
XGN
10
$5.81
$184M cap
Grade F
Xilio Therapeutics, Inc.
XLO
10
$8.62
$56M cap
Grade F
Liquidia Corporation
LQDA
9
$44.40
$4.0B cap
Grade F
Lexicon Pharmaceuticals, Inc.
LXRX
9
$1.78
$716M cap
Grade F
Nuvalent, Inc.
NUVL
9
$123.96
$6.2B cap
Grade F
Outset Medical, Inc.
OM
9
$4.23
$77M cap
Grade F
Apogee Therapeutics, Inc.
APGE
9
$135.07
$2.3B cap
Grade F
Assembly Biosciences, Inc.
ASMB
9
$20.42
$407M cap
Grade F
CytomX Therapeutics, Inc.
CTMX
9
$2.19
$466M cap
Grade F
Dianthus Therapeutics, Inc.
DNTH
9
$86.03
$4.6B cap
Grade F
GRAIL Inc.
GRAL
9
$121.44
$5.3B cap
Grade F
ABVC BioPharma, Inc.
ABVC
9
$0.97
$20M cap
Grade F
BioNexus Gene Lab Corp.
BGLC
9
$0.83
$5M cap
Grade F
CDT Equity Inc.
CDT
9
$0.04
$50M cap
Grade F
Impact BioMedical Inc.
IBO
9
$4.11
$6M cap
Grade F
Sunshine Biopharma, Inc.
SBFM
9
$2.71
$2M cap
Grade F
Synlogic, Inc.
SYBX
9
$1.10
$8M cap
Grade F
Kymera Therapeutics, Inc.
KYMR
8
$131.73
$10.9B cap
Grade F
MaxCyte, Inc.
MXCT
8
$1.26
$135M cap
Grade F
Quanterix Corporation
QTRX
8
$2.90
$131M cap
Grade F
Abeona Therapeutics Inc.
ABEO
8
$4.17
$224M cap
Grade F
Beta Bionics, Inc.
BBNX
8
$15.70
$697M cap
Grade F
Cellectis S.A.
CLLS
8
$1.07
$104M cap
Grade F
CRISPR Therapeutics AG
CRSP
8
$50.07
$4.7B cap
Grade F
Enliven Therapeutics, Inc.
ELVN
8
$49.43
$3.3B cap
Grade F
GH Research PLC
GHRS
8
$18.61
$1.3B cap
Grade F
Trinity Biotech plc
TRIB
8
$5.70
$7M cap
Grade F
Cytosorbents Corporation
CTSO
7
$4.80
$31M cap
Grade F
Pulmonx Corporation
LUNG
7
$2.56
$110M cap
Grade F
MediWound Ltd.
MDWD
7
$14.25
$172M cap
Grade F
Oruka Therapeutics, Inc.
ORKA
7
$102.86
$6.4B cap
Grade F
Personalis, Inc.
PSNL
7
$15.79
$1.7B cap
Grade F
Agenus Inc.
AGEN
7
$7.15
$291M cap
Grade F
Bicycle Therapeutics plc
BCYC
7
$3.61
$240M cap
Grade F
Citius Oncology, Inc.
CTOR
7
$0.51
$46M cap
Grade F
Structure Therapeutics Inc.
GPCR
7
$20.35
$1.1B cap
Grade F
Instil Bio, Inc.
TIL
7
$6.83
$47M cap
Grade F
Lunai Bioworks Inc.
LNAI
7
$0.16
$21M cap
Grade F
Leap Therapeutics, Inc.
LPTX
7
$0.77
$19M cap
Grade F
Myomo, Inc.
MYO
7
$1.21
$47M cap
Grade F
MBX Biosciences, Inc. Common Stock
MBX
6
$51.35
$2.3B cap
Grade F
MacroGenics, Inc.
MGNX
6
$2.33
$141M cap
Grade F
NewAmsterdam Pharma Company N.V.
NAMS
6
$18.90
$2.3B cap
Grade F
Nkarta, Inc.
NKTX
6
$1.73
$112M cap
Grade F
Arcellx, Inc.
ACLX
6
$115.07
$4.6B cap
Grade F
C4 Therapeutics, Inc.
CCCC
6
$3.10
$363M cap
Grade F
Crinetics Pharmaceuticals, Inc.
CRNX
6
$84.95
$3.9B cap
Grade F
Design Therapeutics, Inc.
DSGN
6
$10.21
$605M cap
Grade F
enGene Holdings Inc.
ENGN
6
$1.75
$113M cap
Grade F
Edgewise Therapeutics, Inc.
EWTX
6
$45.04
$4.2B cap
Grade F
4D Molecular Therapeutics, Inc.
FDMT
6
$12.25
$621M cap
Grade F
China Pharma Holdings, Inc.
CPHI
6
$0.57
$2M cap
Grade F
IM Cannabis Corp.
IMCC
6
$0.64
$13M cap
Grade F
Mustang Bio, Inc.
MBIO
6
$0.39
$5M cap
Grade F
Rhythm Pharmaceuticals, Inc.
RYTM
6
$112.28
$7.2B cap
Grade F
SS Innovations International, Inc.
SSII
6
$2.11
$381M cap
Grade F
Vor Biopharma Inc.
VOR
6
$19.88
$1.0B cap
Grade F
XBiotech Inc.
XBIT
6
$1.89
$74M cap
Grade F
Veradermics, Incorporated
MANE
6
$138.78
$5.4B cap
Grade F
BioLineRx Ltd.
BLRX
5
$1.71
$16M cap
Grade F
Microbot Medical Inc.
MBOT
5
$1.11
$72M cap
Grade F
Moderna, Inc.
MRNA
5
$254.19
$96.4B cap
Grade F
Ovid Therapeutics Inc.
OVID
5
$2.85
$504M cap
Grade F
Agios Pharmaceuticals, Inc.
AGIO
5
$29.41
$1.7B cap
Grade F
Arcturus Therapeutics Holdings Inc.
ARCT
5
$10.35
$266M cap
Grade F
Beam Therapeutics Inc.
BEAM
5
$26.41
$2.7B cap
Grade F
BioAge Labs Inc.
BIOA
5
$5.34
$209M cap
Grade F
Benitec Biopharma Inc.
BNTC
5
$9.54
$301M cap
Grade F
Immatics N.V.
IMTX
5
$6.36
$925M cap
Grade F
Protara Therapeutics, Inc.
TARA
5
$2.30
$126M cap
Grade F
Nuvation Bio Inc.
NUVB
5
$4.16
$1.5B cap
Grade F
Arcus Biosciences, Inc.
RCUS
5
$18.28
$2.2B cap
Grade F
SRx Health Solutions Inc.
SRXH
5
$0.81
$8M cap
Grade F
Trevi Therapeutics, Inc.
TRVI
5
$14.33
$1.8B cap
Grade F
MediciNova, Inc.
MNOV
4
$1.46
$71M cap
Grade F
Citius Pharmaceuticals, Inc.
CTXR
4
$0.55
$7M cap
Grade F
Seres Therapeutics, Inc.
MCRB
4
$1.98
$21M cap
Grade F
Mind Medicine (MindMed) Inc.
MNMD
4
$20.69
$1.0B cap
Grade F
Neurogene Inc.
NGNE
4
$25.31
$405M cap
Grade F
Nektar Therapeutics
NKTR
4
$37.26
$1.0B cap
Grade F
Olema Pharmaceuticals, Inc.
OLMA
4
$7.33
$591M cap
Grade F
Vaxcyte, Inc.
PCVX
4
$63.89
$9.7B cap
Grade F
ProQR Therapeutics N.V.
PRQR
4
$1.35
$188M cap
Grade F
Ultragenyx Pharmaceutical Inc.
RARE
4
$15.43
$1.5B cap
Grade F
Arbutus Biopharma Corp
ABUS
4
$3.65
$727M cap
Grade F
Alto Neuroscience, Inc.
ANRO
4
$25.16
$858M cap
Grade F
Anavex Life Sciences Corp.
AVXL
4
$1.15
$103M cap
Grade F
Contineum Therapeutics, Inc.
CTNM
4
$9.52
$311M cap
Grade F
Ginkgo Bioworks Holdings, Inc.
DNA
4
$11.29
$671M cap
Grade F
Inhibikase Therapeutics, Inc.
IKT
4
$1.50
$201M cap
Grade F
Sera Prognostics, Inc.
SERA
4
$2.19
$80M cap
Grade F
Tectonic Therapeutic, Inc.
TECX
4
$20.64
$380M cap
Grade F
Tango Therapeutics, Inc.
TNGX
4
$21.50
$3.5B cap
Grade F
Viridian Therapeutics, Inc.
VRDN
4
$28.49
$3.2B cap
Grade F
Xenetic Biosciences, Inc.
XBIO
4
$1.87
$6M cap
Grade F
Maze Therapeutics, Inc.
MAZE
3
$34.19
$1.8B cap
Grade F
Palisade Bio, Inc.
PALI
3
$1.13
$202M cap
Grade F
uniQure N.V.
QURE
3
$21.70
$1.5B cap
Grade F
Rapport Therapeutics, Inc. Common Stock
RAPP
3
$24.44
$1.1B cap
Grade F
Relay Therapeutics, Inc.
RLAY
3
$18.60
$3.7B cap
Grade F
Alpha Cognition Inc
ACOG
3
$8.29
$127M cap
Grade F
Aclaris Therapeutics, Inc.
ACRS
3
$3.90
$531M cap
Grade F
Candel Therapeutics, Inc.
CADL
3
$8.75
$615M cap
Grade F
Climb Bio, Inc.
CLYM
3
$10.29
$509M cap
Grade F
Compass Therapeutics, Inc.
CMPX
3
$0.76
$123M cap
Grade F
Denali Therapeutics Inc.
DNLI
3
$20.07
$3.2B cap
Grade F
Bright Minds Biosciences Inc.
DRUG
3
$23.00
$204M cap
Grade F
Precision BioSciences, Inc.
DTIL
3
$10.60
$272M cap
Grade F
Fate Therapeutics, Inc.
FATE
3
$1.83
$216M cap
Grade F
ImageneBio Inc
IMA
3
$4.11
$47M cap
Grade F
Disc Medicine, Inc.
IRON
3
$78.91
$3.0B cap
Grade F
INVO Fertility, Inc.
IVF
3
$2.14
$2M cap
Grade F
Sionna Therapeutics, Inc.
SION
3
$3.28
$148M cap
Grade F
China SXT Pharmaceuticals, Inc.
SXTC
3
$2.83
$1M cap
Grade F
Vir Biotechnology, Inc.
VIR
3
$12.21
$1.9B cap
Grade F
Kiora Pharmaceuticals, Inc.
KPRX
2
$1.44
$13M cap
Grade F
Kalaris Therapeutics Inc
KLRS
2
$2.42
$56M cap
Grade F
Ocular Therapeutix, Inc.
OCUL
2
$6.59
$1.4B cap
Grade F
ORIC Pharmaceuticals, Inc.
ORIC
2
$8.82
$880M cap
Grade F
ProKidney Corp.
PROK
2
$1.14
$358M cap
Grade F
Recursion Pharmaceuticals, Inc.
RXRX
2
$3.52
$2.2B cap
Grade F
AC Immune S.A.
ACIU
2
$2.23
$215M cap
Grade F
ADC Therapeutics S.A.
ADCT
2
$1.58
$209M cap
Grade F
Allogene Therapeutics, Inc.
ALLO
2
$1.04
$377M cap
Grade F
Altimmune, Inc.
ALT
2
$2.08
$383M cap
Grade F
Perspective Therapeutics, Inc.
CATX
2
$0.84
$90M cap
Grade F
ClearPoint Neuro, Inc.
CLPT
2
$8.60
$279M cap
Grade F
Cogent Biosciences, Inc.
COGT
2
$31.64
$5.1B cap
Grade F
Foghorn Therapeutics Inc.
FHTX
2
$1.87
$113M cap
Grade F
Immix Biopharma, Inc.
IMMX
2
$8.06
$597M cap
Grade F
Iovance Biotherapeutics, Inc.
IOVA
2
$8.04
$3.5B cap
Grade F
Invivyd, Inc.
IVVD
2
$0.56
$172M cap
Grade F
Jade Biosciences, Inc.
JBIO
2
$15.07
$897M cap
Grade F
NuCana plc
NCNA
2
$0.94
$14M cap
Grade F
Polyrizon Ltd.
PLRZ
2
$11.04
$6M cap
Grade F
Sagimet Biosciences Inc.
SGMT
2
$9.85
$297M cap
Grade F
Taysha Gene Therapies, Inc.
TSHA
2
$4.33
$1.3B cap
Grade F
Tyra Biosciences, Inc.
TYRA
2
$21.15
$1.2B cap
Grade F
Veru Inc.
VERU
2
$2.12
$35M cap
Grade F
vTv Therapeutics Inc.
VTVT
2
$21.03
$86M cap
Grade F
Xenon Pharmaceuticals Inc.
XENE
2
$39.17
$3.6B cap
Grade F
Allarity Therapeutics, Inc.
ALLR
1
$0.96
$27M cap
Grade F
Nautilus Biotechnolgy, Inc.
NAUT
1
$2.23
$274M cap
Grade F
Oculis Holding AG
OCS
1
$7.49
$422M cap
Grade F
OnKure Therapeutics, Inc.
OKUR
1
$2.87
$102M cap
Grade F
Praxis Precision Medicines, Inc.
PRAX
1
$277.62
$7.3B cap
Grade F
Celcuity Inc.
CELC
1
$66.79
$3.1B cap
Grade F
iBio, Inc.
IBIO
1
$0.74
$47M cap
Grade F
Immunome, Inc.
IMNM
1
$18.71
$2.1B cap
Grade F
Wave Life Sciences Ltd.
WVE
1
$3.37
$635M cap
Grade F
Apimeds Pharmaceuticals US, Inc
APUS
1
$2.71
$22M cap
Grade F
PMGC Holdings Inc.
ELAB
1
$1.61
$4M cap
Grade F
SAB Biotherapeutics, Inc.
SABS
1
$3.03
$267M cap
Grade F
Catheter Precision, Inc.
VTAK
1
$0.15
$1M cap
Grade F
Whitehawk Therapeutics Inc
WHWK
1
$3.13
$172M cap
Grade F
X4 Pharmaceuticals, Inc.
XFOR
1
$3.18
$304M cap
Grade F
Eupraxia Pharmaceuticals Inc.
EPRX
0
$6.89
$436M cap
Grade F
Aprea Therapeutics, Inc.
APRE
0
$0.52
$6M cap
Grade F
Milestone Pharmaceuticals Inc.
MIST
0
$0.76
$86M cap
Grade F
ArriVent BioPharma, Inc.
AVBP
0
$13.64
$603M cap
Grade F
Capricor Therapeutics, Inc.
CAPR
0
$9.00
$498M cap
Grade F
Dare Bioscience, Inc.
DARE
0
$0.64
$9M cap
Grade F
Evommune, Inc.
EVMN
0
$6.65
$231M cap
Grade F
Advanced Biomed Inc. Common Stock
ADVB
0
$1.98
$4M cap
Grade F
Clearmind Medicine Inc.
CMND
0
$5.58
$2M cap
Grade F
PRF Technologies Ltd.
PRFX
0
$0.87
$0M cap
Grade F
Shuttle Pharmaceuticals Holdings, Inc.
SHPH
0
$5.58
$1M cap
Grade F
SELLAS Life Sciences Group, Inc.
SLS
0
$8.42
$1.6B cap
Grade F
Spruce Biosciences, Inc.
SPRB
0
$46.55
$123M cap
Grade F
Unicycive Therapeutics, Inc.
UNCY
0
$3.55
$95M cap
Grade F
No stocks match your filter criteria.